Newsfiscal.ai
Imunon Enters Agreement to Sell ThermoDox® Rights to VoxelDox Therapeutics
· Published
Article summary
Imunon, Inc. has announced an agreement to divest its rights to ThermoDox®, a heat-activated liposomal formulation of doxorubicin, to VoxelDox Therapeutics, Inc.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…